The myeloid-related proteins MRP8 (S100A8) and MRP14 (S100A9), two members of the S100 family of calcium-binding proteins, are co-expressed and form a cell-surface and cytoskeleton-associated heterodimer upon calcium mobilization which is recognized by the mAb 27E10. The heterodimer is abundantly expressed in the cytoplasm of granulocytes and a subpopulation of blood monocytes. Previously, we and others demonstrated endothelium-associated MRP8/14 in inflamed tissues in the vicinity of transmigrating leukocytes, suggesting a function of the proteins in this process. Here, we demonstrate that 27E10 ⍣ cells represent a fast-migrating monocyte subpopulation which preferentially utilizes an ICAM-1-dependent mechanism. The following observations imply a function of MRP8/14 in the transmigration process: (i) higher secretion of MRP8/14 from 27E10 ⍣ monocytes compared to 27E10 -monocytes after interaction with activated endothelium, (ii) higher expression of CD11b on 27E10 ⍣ compared to 27E10 -monocytes, (iii) up-regulation of CD11b on 27E10 -monocytes in the presence of MRP14 or MRP8/14 heterodimers but not MRP8 and (iv) active participation of MRP14 but not of MRP8 in transmigration as shown by blocking with respective antibodies. We show that the interaction of 27E10 ⍣ monocytes with activated endothelium leads to MRP8/14 release which may account for the high MRP8/14 concentrations in body fluids of patients with acute or chronic inflammatory diseases. Released MRP8/14 may serve a function by enhancing CD11b expression and/or affinity in human monocytes and by participating in the transendothelial migration mechanism. Thus, MRP8/14 substantially contributes to the recruitment of monocytes to an inflammatory site.
Introduction
The onset of an inflammatory reaction is characterized by A predominant subpopulation of monocytes in the peripheral blood is characterized by the expression of myeloid the recruitment of first granulocytes and later monocytes to the tissue site. The events of adhesion and transmigration of related-proteins MRP8 (S100A8) and MRP14 (S100A9), two members of the S100 family of calcium binding proteins (6-granulocytes involve a cascade of steps mediated by selectins and the leukocyte β 2 integrins (CD11/CD18) (1). 9). These cells were shown to be among the first cells infiltrating acutely inflamed tissues in several diseases like Monocytes are a heterogeneous population comprising the precursors for different tissue macrophages. It has been contact dermatitis and gingivitis in humans, and irritative and allergic contact dermatitis and leishmaniasis in mice (2,6,10-shown that different monocyte populations emigrate at different times in an ordered sequence into the tissue in the course 13). MRP8 and MRP14 are cytosolic proteins which are expressed in monocytes but are absent in mature tissue of an inflammatory reaction (2) . While the early-infiltrating monocytes seem to share some of the mechanisms for macrophages (14, 15) . Under inflammatory conditions and/or upon calcium mobilization, MRP8 and MRP14 are translocated adhesion and transmigration with granulocytes, laterappearing monocyte subpopulations seem to utilize other to the plasma membrane and to the cytoskeleton (16, 17) . Both proteins form a heterodimer which is specifically recogmechanisms such as CD14 and RM3/1 (CD163), a newly defined member of the scavenger receptor family (4, 5) .
nized by the mAb 27E10 (18).
While both proteins are integrated into the plasma mem-HMEC-1 cells were derived from human dermal microvascular EC (isolated from human foreskin) which were immortalized brane upon calcium mobilization, they are secreted after stimulation with phorbol myristate acetate (PMA) via a novel by transfection with a pSVT plasmid containing the full coding region of the large T antigen of the simian virus 40A (33) . The protein kinase C-dependent pathway (19) indicating two different cellular pathways. The surface expression of the cells were cultured in MCDB basic medium (Gibco, Karlsruhe, Germany), supplemented with epidermal growth factor (10 heterodimeric complex correlates with monocyte activation and can be induced in vitro with the calcium ionophore ng/ml), hydrocortisone (1 µg/ml) and 10% FCS at 37°C and 5% CO 2 . Both cell lines expressed the endothelial marker A23187, IFN-γ and lipopolysaccharide (16) .
MRP8/14 complexes are found in high concentrations in proteins PECAM (CD31) and von Willebrand factor (vWF) constitutively. body fluids of patients with acute and chronic diseases, and have been proposed to represent new inflammation markers Purification of MRP8, MRP14 and the MRP8/14 heterodimer (20 -22) . The function of these proteins is obviously pleiotropic. complex Some of the intra-and extracellular functions are now gradually emerging. The heterodimer seems to have fungistatic and MRP8 and MRP14 as well as the heterodimer MRP8/14 complex were purified from human granulocytes which were bacteriostatic properties presumably mediated by its zincbinding properties (23, 24) . Recently, it was shown that the prepared from buffy coats as previously described (34).
In some experiments human recombinant MRP8 and MRP14 heterodimer also binds arachidonic acid with high affinity (25,26). In previous studies on cryostat sections of inflamed were used which were prepared as previously described (25). Briefly, MRP8 and MRP14 were subcloned into pQE 32, tissues, not only cells adhering to the endothelium but also the endothelium itself stained positive for MRP8/14 (27) . This expressed and purified as follows. Bacteria were washed and lysed using lysis buffer consisting of 50 mM NaH 2 PO 4 , 20 is an indication for a role of MRP8/14 in the adhesion and migration of myeloid/monocytic cells through vascular mM Tris-HCl, 8 M urea and 100 mM NaCl (Buffer 1, final pH 6.0). All chemicals were obtained from SERVA (Heidelberg, endothelium. In this context, an interesting novel function was recently described for MRP14 which was shown to regulate Germany). The lysate was sonified and centrifuged at 20,000 g for 30 min. The proteins were tagged with a 6ϫhistidine neutrophil adhesion to fibrinogen via β 2 integrin (CD11b/ CD18, Mac-1) affinity control (28).
residue for purification on a TALON TM metal-affinity column (Clontech, Palo Alto, CA) using a denaturing protocol. After In order to shed more light on the cellular functions of MRP8/14 we studied adhesion and transendothelial migration binding on the column the proteins were washed with Buffer 1 containing 10 mM imidazole (pH 7.0) to avoid unspecific of 27E10 ϩ and 27E10 -monocytes. We were able to show for the first time that 27E10 ϩ monocytes preferentially migrate binding. The proteins were eluted by the use of Buffer 1 containing 150 mM imidazole (pH 6.0). In order for the proteins through vascular endothelium in contrast to 27E10 -monocytes. By using FACS-sorted monocyte subpopulations we to renature they were dialysed stepwise against decreasing urea concentrations. Subsequent PAGE revealed a protein show a function of MRP14 and the MRP8/14 complex but not MRP8 in the regulation of the β 2 integrin Mac-1 (CD11b). In purity of ജ98% (data not shown). The proteins were aliquoted and stored at -70°C or at 4°C for short-term use. All MRP addition we found that antibodies against MRP14 can block transendothelial migration (TEM) of 27E10 ϩ human monocytes preparations were checked for endotoxin content by the use of a LAL test (Biowhittaker, Walkersville, MD) and ensured to through an EC monolayer. be ഛ0.05 EU/ml.
Methods

Antibodies Cells and cell culture
The following antibodies were used in this study. Polyclonal monospecific antisera were raised in rabbits against recomHuman peripheral blood leukocytes were obtained from buffy coats of normal healthy donors. Monocytes were isolated in binant MRP8 and MRP14. The antibodies were purified by affinity chromatography, and specificity was evaluated by a two-step gradient centrifugation procedure as previously described (6) or by leukapheresis using a cell separator Western blotting using recombinant proteins and transfected human L134 lung fibroblast cell lines as described earlier CS 3000 plus Omnix (Baxter, Unterschleissheim, Germany). Monocytes were cultured in McCoy's A5 medium (Biochrom, (7, 17) . The mAb 27E10 from our laboratory was employed to detect the MRP8/14 heterodimer complex (12 µg/ml). This Berlin, Germany) and 20% (v/v) human serum in Teflon bags at 37°C and 7% CO 2 . For activation, monocytes were treated antibody recognized the complex only, but not the MRP8 or MRP14 monomers (6, 18) . A mAb against ICAM-1 was used with 1 µM calcium ionophore A23187 (Sigma, Deissenhofen, Germany) for 1 h. The purity of the monocyte population was (84H10, 0.2 mg/ml; Immunotech, Hamburg, Germany). The CD11b (MAC-1) mAb was obtained from Dako (Hamburg, estimated to be ജ95%. The cells were cultured in Teflon bags as previously reported (6) . All media, substances and cell Germany; 2LPM19C) and used at a concentration of 1 µg/ml for immunostaining and 6 µg/ml for blocking experiments. culture devices were free of endotoxin contamination.
The human macrovascular endothelial cells (HUVEC) were Antibodies against CD62E (E-selectin) were purchased from R & D Systems (Wiesbaden, Germany) and against CD106 prepared as previously described (3) Flow cytometry and FACS activation EC were treated with tumor necrosis factor (TNF)-α (0.5 ng/ml) for 24 h. For transmigration, 600 µl of transmigration To minimize unspecific binding, cells were preincubated in 1% BSA/PBS for 1 h at 4°C. For each analysis, 1ϫ10 6 medium were added to the lower part of the chamber (complete RPMI 1640 medium, supplemented with 10% FCS and cells were incubated with a FITC-conjugated 27E10 antibody (dilution 1:40 with HBSS) or with the isotype-matched control 25 mM HEPES) and 2ϫ10 6 monocytes were added for TEM. The cells were allowed to migrate for the indicated time respectively. Staining was performed in the dark at 4°C for 60 min. Cells were stained with propidium iodide to discriminperiods at 37°C. The number of migrated cells was counted using a hemocytometer or a Coulter counter after placing the ate dead cells and kept on ice until measurement. Flow cytometry and cell sorting were performed on a Moflo plate on ice for 30 min to reverse possible monocyte attachment to the plastic. The filters were saved for later microscopic high speed sorter and analyzer (Cytomation, Boulder, CO), equipped with an argon ion laser (Coherent, Palo Alto, CA) evaluation of EC density. Trypan blue exclusion was performed to analyze viability. To study the composition of monocyte (excitation wavelength of 488 nm). Data acquisition was performed using CyCLOPS 3.4 software (Cytomation). Forsubpopulations of migrated cells, cytospin slides were prepared (5ϫ10 4 cells per slide), fixed with acetone for 10 min ward light scattering (FSC), orthogonal light scattering (SSC) and fluorescence signals (FL1 and FL3) were acquired, and and immunostained with 27E10 or IgG1 as isotype control. At least 400 cells per slide were counted using a microscopic stored in list mode data files. Each measurement contained a defined number of 10,000 propidium iodide-negative, vital grid. Triplicate counts were performed in all experiments.
cells. Gates of the bivariate and univariate histograms were Immunohistochemistry logically connected in the following order: vital cells from gate 1 of propidium iodide/FSC and leukocytes from gate 2 of Cytospin preparations were fixed in acetone as described above, air dried for at least 1 h and submersed in PBS.
FSC/SSC to univariate FITC. The separately gated FITC signals at the mode values of 27E10 -and 27E10 ϩ cells with defined Antibodies were diluted in 1% BSA in PBS. For negative controls non-specific mouse or rabbit IgG were used at FSC, SSC, FL1 and FL3 characteristics were simultaneously isolated with a sort rate of 20,000 cells/s. Contamination with concentrations corresponding to the specific test antibodies. Endogenous peroxidase was blocked by 20 mM NaN 3 (Merck, lymphocytes was avoided by careful outgating of these cells before sorting. Lymphocyte contamination was ensured to be Darmstadt, Germany) and 0.1% H 2 O 2 (Merck) in PBS for 5 min at room temperature. Non-specific binding was blocked Ͻ5% in the sorted cell populations by staining with a CD3 mAb (PharMingen, via Beckton Dickinson, Heidelburg, Germany) by incubating the slides in 1% BSA for 1 h. The primary antibody was applied for 1 h at room temperature (1:40 using either FACS analysis or cytospin slides. The separated populations were allowed to rest at least 2 h at 37°C after dilution of a 12 µg/ml stock solution for 27E10, 1:100 dilution for ICAM-1). After thorough washing with 0.01% BSA, slides sorting in fresh medium before use in the assays. were treated with the conjugated secondary antibody for 1 h MRP8/14 secretion after EC interaction at room temperature. Substrate reaction was performed with 0.01 M H 2 O 2 containing amino-9-ethyl-carbazol (Sigma) in Monocytes at 2ϫ10 5 /well (either 27E10 -or 27E10 ϩ ) were added to 5ϫ10 4 HUVEC which were plated in 96-well plates dimethylformamide. Slides were counterstained with Mayers' Hemalaun (Merck).
2 days in advance. EC were either left untreated (medium) or activated with TNF-α for 24 h. After incubating 16 h at CD11b ligand binding assay 37°C supernatants were collected and analyzed for lactate dehydrogenase (LDH) activity as vitality and membrane integMonocytes (1ϫ10 6 ) were pretreated with 20 µg/ml of recombinant human MRP8, MRP14 or MRP8/14 complex rity marker as described elsewhere (17). MRP secretion was assessed by the use of a sandwich ELISA as described earlier respectively for 60 min at 37°C. After washing twice with PBS, sICAM-1 (R & D Systems) at a concentration of 10 µg/ml was (17,35). EC (TNF-α treated or untreated) without monocytes served as background controls. added for ligand binding and incubated for 30 min at 37°C. After washing twice again, the amount of bound sICAM-1 on
Respiratory burst assay the cell surface (ligand binding) was estimated by immunostaining for ICAM-1 with an anti-CD54 antibody (Immunotech) Monocytes (2ϫ10 6 ; 200 µl) were treated with 10 µl of a 10 mM cytochrome c stock solution and the activator in an in a 1:100 dilution. Immunostaining was evaluated by flow cytometry. Medium-treated monocytes served as a negative appropriate dilution. The reaction mixture was diluted to a final volume of 1 ml with HBSS containing 5 mM glucose. the coverslips were mounted on a thermostated microscope tissue chamber, washed 3 times with HEPES buffer (146 mM As a reference the same reaction mixture was prepared containing 10 µl of a 5 mg/ml superoxide dismutase stock NaCl, 5 mM KCl, 0.5 mM MgCl 2 , 1.4 mM Na 2 HPO 4 , 5 mM dextrose, 20 mM HEPES and 1 mM CaCl 2 ) and incubated solution in addition. After incubating for 30 min at 37°C the samples were immediately cooled down on ice, the cells were with 1 ml of the same buffer. Fields of~10 cells were visualized on a Zeiss (IM35) inverted microscope and excited alternately centrifuged and absorption of the supernatants was measured at 550 nm wavelength using the samples containing superoxat 340/380 nm. The emission was measured at 510 nm using a photon counting detector. The 340 and 380 nm tracings ide dismutase as reference. Molar concentration of superoxide radicals was estimated using the formula: M [mol/l] ϭ absorpwere corrected in each experiment and the autofluorescence was subtracted before calculating the 340/380 ratio (38) tion 550 nm /21.1ϫ10 -3 M -1 .
Measurement of intracellular [Ca 2ϩ ]
Statistical analysis Monocytes were cultured on glass coverslips which were
The experimental results were analyzed for their statistical coated with fibronectin (50 µg/ml). The cells were loaded with significance by two-tailed Student's t-test with P ഛ 0.05. 5 µM Fura-2/AM in culture medium for 10 min at 37°C. Then
Results
Migration of 27E10 ϩ monocytes
TEM of human monocytes through macrovascular HUVEC and microvascular HMEC-1 was studied using a modified Boyden chamber assay. Monocytes were allowed to migrate for the indicated time intervals (2-30 h) and the total number of migrated cells was counted as well as the percentage of migrating monocytes staining positive for 27E10. Spontaneous monocyte TEM through HMEC-1 was found to be delayed compared to monocyte TEM through HUVEC at 4 h (Fig. 1) . The rate of total TEM across HMEC-1 plateaued after 24 h (Fig. 1b) , whereas a steady increase of migration was observed using HUVEC (Fig. 1a) . Peak migration time for the 27E10 subpopulation through HUVEC was determined to be 4 h. At this early time point the majority of 27E10 ϩ cells pass the EC layer, whereas most of the monocytes staining negative for 27E10 migrate later (6-24 h). The peak migration time for 27E10 ϩ cells through HMEC-1 was determined to be 8 h.
ICAM-1-dependent transmigration of 27E10 ϩ monocytes
In order to identify mechanisms by which 27E10 ϩ monocytes migrate through EC we compared the expression and inducibility of a panel of adhesion molecules on both HUVEC and HMEC-1 before and after stimulation with TNF-α, and correlated it with the TEM of 27E10 ϩ monocytes. Corresponding with previously published findings, HUVEC cells were shown to constitutively express ICAM-1 (42.9 Ϯ 9.3% positive cells). In contrast, ICAM-1 expression on untreated HMEC-1 was negligible in single cells (Fig. 2a) . After activation with TNF-α both cell types expressed high amounts of ICAM-1 (82.9 Ϯ 3.2 and 84.9 Ϯ 3.5% positive cells respectively). Both cell types stained positive for the two EC markers CD31 and vWF, and could not be up-regulated by TNF-α treatment (Fig. 2a) . The expression of E-selectin and VCAM-1 on HUVEC was induced after 4 h treatment with TNF-α from a basic level of~5 to 20 or 40% positive cells respectively, whereas the Using monospecific polyclonal antibodies directed against adhesion molecules on untreated and stimulated HUVEC and either MRP8 or MRP14 and a mAb against the MRP8/14 HMEC-1 was compared, a clear correlation became apparent heterodimer (27E10) we investigated which of the proteins only for ICAM-1 ( Fig. 2a and b) but not for the other adhesion are functionally essential for successful TEM of the 27E10 ϩ molecules tested. In addition, we found a mAb against ICAMmonocyte subpopulation. Monocytes staining surface-positive 1 to efficiently but not completely inhibit TEM of 27E10 ϩ for 27E10 to 50.4% were preincubated with the respective monocytes through HUVEC (Fig. 2c) . The experiment was blocking antibodies and added to activated HUVEC for TEM. controlled by an antibody against an irrelevant epitope (antiAnti-MRP14 was found to effectively inhibit TEM of 27E10 ϩ IgG1). These data indicate the involvement of ICAM-1 as a monocytes (41.4 Ϯ 2.1% inhibition), whereas anti-MRP8 did key molecule for TEM of 27E10 ϩ monocytes.
not show an inhibitory effect (Fig. 4) . The monoclonal 27E10 antibody inhibited TEM by 14.6 Ϯ 2.7%. The experiment was MRP8/14 secretion of 27E10 ϩ and 27E10 -monocytes after controlled by a monoclonal mouse IgG and a polyclonal contact with EC rabbit IgG antibody. Equal antibody binding to the monocyte surface was ensured by FACS staining (Fig. 4a-c) . In a next set of experiments we investigated the ability of FACS-sorted 27E10 ϩ and 27E10 -cells to secrete MRP8/14 MRP14 and MRP8/14 induced regulation of CD11b expresinto the supernatant after contact with native and activated sion/activation EC. We found a high rate of MRP8/14 secretion from 27E10 ϩ cells (352 Ϯ 38 ng/U) after contact with activated EC (Fig. The obvious participation of MRP14 in monocyte TEM raised the question whether MRP14 or MRP8/14 function as adhe3a). The release of MRP8/14 from 27E10 -monocytes to activated HUVEC was significantly lower. MRP secretion was sion-like molecules themselves or whether known adhesion mechanisms are controlled by MRP. CD11b (Mac-1) as a key also lower after contact with untreated endothelium for both 27E10 ϩ and 27E10 -monocytes. MRP release was controlled molecule being responsible for firm leukocyte adhesion to the endothelium via ICAM-1-and fibrinogen-ligand binding by measuring unspecific cytoplasmic protein release (LDH). We also measured only a low MRP8/14 secretion when the was studied under the influence of MRP8, MRP14 and the MRP8/14 heterodimer. We tested binding of sICAM-1 to monocytes were incubated for the same time in cell-free conditioned medium of untreated or TNF-α-activated HUVEC its counter-receptor CD11b by flow cytometry and found it significantly increased in the presence of MRP14 (84.6% cells (Fig. 3b) . We, therefore, conclude the requirement of direct EC to monocyte contact for MRP8/14 secretion.
staining positive for CD54 versus 36.2% in control cells) and MRP8/14 complex (79.6% positive cells versus 36.2% in sion. As we found by flow cytometry, 27E10 ϩ monocytes stain highly positive for CD11b, whereas mean fluorescence was medium treated cells), whereas MRP8 had no effect (Table  1) . MnCl 2 , a known regulator of CD11b affinity, was used as lower in 27E10 -monocytes (Fig. 6b) . When 27E10 -monocytes were incubated with MRP8 (20 µg/ml for 4 h) CD11b mean positive control. Since ICAM-1 serves not only as a ligand for CD11b but also for LFA-1 (CD11a), we performed a control fluorescence was either slightly down-regulated or not affected (Fig. 6b) . In contrast, MRP14 and MRP8/14 up-regulated experiment in which the cells were pretreated with an anti-LFA-1 antibody in order to saturate CD11a binding sites.
CD11b to an extent similar to 27E10 ϩ cells (Fig. 6b) . During the process of TEM, monocytes pass different Similar results were obtained after subsequent incubation with MRP8, MRP14, MRP8/14 and the sICAM-1 ligand (see stages of intracellular activation and regulation of cell surface molecules. This process includes enhancement of adhesion Table 1 , insets).
Since we were not able to find evidence for a direct molecule expression, production of cytokines and superoxide radical formation. In order to analyze whether MRP14 and binding of MRP14 or MRP8/14 to CD11b (immunoprecipitation experiments, data not shown), an indirect activation mech-MRP8/14 complex mediated up-regulation is a specific effect we studied the influence of these proteins on other monocyte anism, presumably via another so far not identified receptor, is supposed. In a next experiment the sensitivity of this activation parameter as well. As expected, oxidative burst was clearly increased in supernatants of cells treated with PMA putative receptor/binding protein to Bordetella pertussis toxin was studied by investigating MRP14-mediated sICAM binding (10 µg/ml), whereas none of the MRP-stimulated superoxide radical production in the cells (Fig. 7a) . Increase of intracellular (Fig. 5) . Ligand binding to CD11b, up-regulated by MRP14 but not influenced by MRP8, was dose-dependently inhibited calcium is a characteristic signal during cellular activation by various stimulants. As indicated in Fig. 7(b) , 50 µM histamine in the presence of 0-1 µg/ml pertussis toxin, suggesting a Gprotein-coupled activation mechanism.
caused a clear increase in intracellular Ca 2ϩ concentration within 60 s after addition, whereas MRP8 and MRP14 failed To substantiate the idea that MRP14 and the heterodimer complex are involved in the regulation of CD11b expression to induce such a Ca 2ϩ flux even after up to 10 min after addition of the substances. Cells only slightly responded to and/or activation, we analyzed 27E10 ϩ and 27E10 -monocytes (isolated by FACS sorting) with regard to their CD11b expresstimulation with MRP8/14 complex over a period of 10 min. with other adhesion molecules. This is supported by our experiments (Fig. 2 ) using the microvascular cell line HMEC-1 which expressed ICAM-1 to a low extent in singular cells when untreated. Both ICAM-1 expression and TEM of the 27E10 ϩ monocyte population can be induced by TNF-α in this cell line. The inhibition of 27E10 ϩ monocyte TEM by a CD54 mAb (Fig. 2C ) further underlines the importance of this molecule for functional diapedesis of these cells. The fact that TEM of these cells is not completely suppressed by anti-CD54 points to the probability that other AM contribute to a Monocytes were pretreated with recombinant MRP8. MRP14 or the MRP8/14 heterodimer complex (20 µg/ml) and HBSS as control TEM of this monocyte subpopulation as well. 27E10 ϩ monocytes (Fig. 4) . This raises the question whether are missing fundamental and typical structural properties of that MRP14 occupies (a) binding site(s) on the surface of cells with myelo/monocytic origin there is no evidence for a adhesion molecules such as transmembrane domains makes it less likely that MRP14 and/or MRP8/14 directly function as direct binding of MRP to β 2 integrins so far (28,29). In neutrophils, CD11b affinity was shown to be regulated indirmembrane-associated adhesion molecules. We demonstrate that MRP14 and the MRP8/14 complex, but not MRP8, differenectly by MRP14 (28). Since we could not find evidence for a direct binding of MRP14 and CD11b in our system either, we tially affect CD11b expression/activation and ICAM-1 ligand binding in monocytes. Two major conclusions can be drawn:
assume that this is also true for monocytes. The pertussis toxin sensitivity of MRP14-mediated sICAM binding to CD11b (i) ICAM-1 binding to human monocytes is enhanced in the presence of MRP14 and the heterodimer MRP8/14 complex, points to a G protein-dependent receptor mechanism which is responsible for the up-regulation. However, the enhanced but not in the presence of MRP8, and (ii) 27E10 -monocytes express spontaneously less CD11b than 27E10 ϩ cells, but binding of sICAM-1 to monocytes in the presence of MRP14 and the MRP8/14 complex is a sign for an increased CD11b CD11b expression can be stimulated by external addition of MRP14 and MRP8/14 complex. Although it has been shown binding capacity which may be due to either (i) activation of previously expressed but non-active CD11b epitopes, (ii) found in high concentrations in body fluids of patients with inflammatory diseases. This raises the question about the increased CD11b affinity or avidity or (iii) a combination of both mechanisms. Since the ligand assay, as it was used in natural secretion stimulus of these proteins which are almost exclusively found as heterodimeric complexes after release. this study (Table 1) , measures both increased expression and enhancement of CD11b affinity, no differentiation between the The assumption that the interaction of monocytes with activated endothelium represents the natural signal for MRP both effects can be made at this point. The fact that MRP14 and the MRP8/14 complex increase CD11b antigenic density release was investigated in the present study. As we show, MRP8/14 is primarily released from activated (27E10 ϩ ) monoas measured by enhancement of mean fluorescence relative to the control makes it most likely that cell adhesion strength cytes after contact with TNF-α-activated EC. We, therefore, identified one of the natural MRP release signals from monoto EC is enhanced. The situation in monocytes is apparently somewhat different from that in neutrophils (28) since we cytes which is triggered by activated endothelium and which give an explanation for the fact that MRP plasma levels are observed an up-regulation of CD11b antigenic density and induction of sICAM-1 ligand binding not only by MRP14 (like elevated in patients with inflammatory diseases. MRP can, thus, be considered a representative early marker for inflamin neutrophils) but also by the MRP8/14 complex. So far, we and others could not demonstrate release of the individual matory processes in human plasma. The contribution of MRP released from apoptotic cells, e.g. neutrophils, to the increase proteins MRP8 or MRP14. According to our knowledge, the MRP heterodimer complex represents the only naturally of MRP plasma levels is minor in the early events of inflammation since these cells are recognized and phagocytosed occurring and biologically relevant form. As we recently showed by MALDI mass spectroscopy (37,39) the tetrameric quickly (32). Any effect of MRP on leukocytes would require binding to complex seems to be the most stable complex implying that this is the biologically active form. There are only rare situations the cell surface and signal transduction. Even though the chemical identification of receptors for either MRP8 or MRP14 where MRP8 or MRP14 are expressed as monomers by infiltrating cells (31). Whether they are released individually is lacking, convincing evidence for their existence has been published in myelo-monocytic cells (30). Preliminary data as well is currently unknown. It is very unlikely that the used MRP8/14 complex preparation contained significant amounts suggest the existence of MRP binding sites also on human EC. Taken together with our recent findings the possibility of monomeric MRP 14 (which might have caused activation effects). We ensured equality of MRP8 and MRP14 amounts becomes likely that primarily 27E10 ϩ monocytes release MRP8/14 after contact to EC which ligates to a EC associated in the preparation by quantitative densitometric analysis of the gel bands after SDS-PAGE (34). Since the proteins are counter-receptor. This could be a mechanism for the preferential adhesion and transmigration of MRP expressing monoknown to form heterodimer complexes under physiological conditions we presume no monomer contamination of the cytes. Further investigation is needed to verify this assumption. MRP8/14 complex. Also, after diluting out the complex or removing it by precipitation with the only MRP8/14 complex
